Long-term outcomes of autologous PBSCT for peripheral T-cell lymphoma: Retrospective analysis of the experience of the Fukuoka BMT group

A. Numata, T. Miyamoto, Y. Ohno, T. Kamimura, K. Kamezaki, T. Tanimoto, K. Takase, H. Henzan, K. Kato, K. Takenaka, T. Fukuda, N. Harada, K. Nagafuji, T. Teshima, K. Akashi, M. Harada, T. Eto

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Peripheral T-cell lymphoma (PTCL) is generally characterized by poor prognosis after conventional chemotherapy compared with aggressive B-cell lymphoma. To elucidate the role of high-dose chemotherapy (HDCT) with auto-SCT, we retrospectively analyzed the outcomes of 39 patients with PTCL who received HDCT and auto-SCT between 1990 and 2005. Eleven patients were histologically typed as angioimmunoblastic, nine as anaplastic large-cell lymphoma, seven as natural killer/T-cell lymphoma and twelve as PTCL unspecified. Clinical conditions at transplantation were complete response (CR) in 27 patients and non-CR in 12 patients. Thirty-two patients received a pre-transplant conditioning regimen (MCEC) comprising ranimustine, carboplatin, etoposide and CY, and seven did other TBI-based regimens. Rapid engraftment awas obtained in all cases, and transplant-related death was not seen. An estimated 5-year OS was 62.1% with a median follow-up of 78 months. The 5-year OS was significantly higher in patients transplanted during complete response than in those during other disease status (71.4% vs 27.3%, P0.046). HDCT supported by auto-SCT may therefore be effective as consolidation in CR for PTCL treatment.

Original languageEnglish
Pages (from-to)311-316
Number of pages6
JournalBone Marrow Transplantation
Volume45
Issue number2
DOIs
Publication statusPublished - Feb 1 2010

All Science Journal Classification (ASJC) codes

  • Hematology
  • Transplantation

Fingerprint Dive into the research topics of 'Long-term outcomes of autologous PBSCT for peripheral T-cell lymphoma: Retrospective analysis of the experience of the Fukuoka BMT group'. Together they form a unique fingerprint.

  • Cite this

    Numata, A., Miyamoto, T., Ohno, Y., Kamimura, T., Kamezaki, K., Tanimoto, T., Takase, K., Henzan, H., Kato, K., Takenaka, K., Fukuda, T., Harada, N., Nagafuji, K., Teshima, T., Akashi, K., Harada, M., & Eto, T. (2010). Long-term outcomes of autologous PBSCT for peripheral T-cell lymphoma: Retrospective analysis of the experience of the Fukuoka BMT group. Bone Marrow Transplantation, 45(2), 311-316. https://doi.org/10.1038/bmt.2009.165